These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12856249)

  • 1. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
    von Lindern JJ; Niederhagen B; Bergé S; Appel T
    J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin and Percutaneous Needle Electrolysis for the Treatment of Chronic Masticatory Myalgia.
    Gonzalez-Perez LM; Vera-Martin R; Montes-Latorre E; Torres-Carranza E; Infante-Cossio P
    Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study.
    Freund BJ; Schwartz M
    Headache; 2000 Mar; 40(3):231-6. PubMed ID: 10759926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
    Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
    J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
    von Lindern JJ
    Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.
    Khawaja SN; Scrivani SJ; Holland N; Keith DA
    J Oral Maxillofac Surg; 2017 Nov; 75(11):2307-2315. PubMed ID: 29078865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.